Celularity

• CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

  Phase 1/2, Terminated, 1 person, Jan 26, 2022

• A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)

  Phase 1, Terminated, 10 people, May 24, 2016

Sources: clinicaltrials.gov

• The therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases

  Mar 7, 2026

Sources: api.crossref.org

• Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans

  Consulting or advice, Feb 18, 2026

• Senescence, NK cells, and cancer: navigating the crossroads of aging and disease

  Employment, Apr 4, 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Business Wire